6th Edition Royalty Rates for Pharmaceuticals & Biotechnology, 6th Edition reports royalty rates for an incredible range of compounds, manufacturing techniques, therapies and other pharmaceutical and biotechnology patented inventions. Just some of the technology categories covered include attention deficit disorder, Alzheimer’s detection, anti-inflammatory, antifungal, antiviral, arthritis, bone marrow production, cancer, cardiovascular, cartilage regeneration, chromosome analysis, cold remedies, contraception, cystic fibrosis, dermatology, diabetes, drug delivery, gene alteration, hepatitis, HIV, humanized antibodies, monoclonal antibodies, neurological, pain therapy, personal care, psychotherapy, research processes, sleep therapy, stem cells, transdermal drug delivery, and vaccines. This book presents detailed financial information about third party transactions that center on the transfer of biotechnology and pharmaceutical technology. The parties are identified, the technology is described and all of the financial terms available are reported including royalty rates, license fees and milestone payments. This new edition also presents seven financially based models for pricing and valuing biotech and pharmaceutical technology. Comprehensive illustrations are provided.
By Gordon V. Smith and Russell L. Parr
This is the latest book by Smith and Parr designed to simplify the process of attaching a dollar amount to intellectual property and intangible assets. In this new 864-page book the authors combine their previous books on Valuation, Licensing and Infringement Damages into one comprehensive treatise. The book is divided into three sections. The Valuation section has been updated to include new valuation examples, the latest accounting standards and more details about special case valuation assignments. The Exploitation section includes methods for valuing joint venture intellectual property contributions and determining royalty rates for licensing. In the Infringement Damages section reasonable royalties, lost profits and price erosion are discussed for patents, trademarks and copyrights along with a new discussion about key cases important to establishing infringement damages. This is a must have book for all aspects of managing intellectual property.
The experts at Navigant Consulting, Inc. have analyzed a mountain of data to provide detailed statistics and trends about patent infringement damages. Graphs, tables and insightful narrative provide detailed answers to once vexing questions. This new book will confirm long held suspicions for some readers and thoroughly surprising insights for others. Have you ever wondered whether there is an advantage to bench trials over juries? The answer is in this new book. Have you ever wondered how often enhanced damages are awarded? Read this book. Do you think lost profits are the only way to gain a substantial award? Did you know that infringement cases are being filed faster than new patents are being granted? This book has the answers. Did you know that royalty rates awarded at trial are often higher than those negotiated outside of trial. Did you know that jury awards are overturned more often than bench awards? Did you know that over 60% patent infringement awards are comprised of only royalty rates? These are just some of the insights provided by this new book. Purchase a copy today.